| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3861528 | The Journal of Urology | 2015 | 6 Pages |
Abstract
A substantial proportion of patients with metastatic prostate cancer present with a synchronous second primary malignancy. Definitive therapy targeting prostate cancer may confer a limited survival benefit in patients with synchronous lung or stomach cancer.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Kyo Chul Koo, Hanna Yoo, Ki Hong Kim, Sang Un Park, Kyung Seok Han, Koon Ho Rha, Sung Joon Hong, Seung Choul Yang, Byung Ha Chung,